Literature DB >> 25196510

Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project.

M Elbatarny1, S Mollah, J Grabell, S Bae, M Deforest, A Tuttle, W Hopman, D S Clark, A C Mauer, M Bowman, J Riddel, P A Christopherson, R R Montgomery, M L Rand, B Coller, P D James.   

Abstract

Bleeding Assessment Tools (BATs) have been developed to aid in the standardized evaluation of bleeding symptoms. The Vicenza Bleeding Questionnaire (BQ), published in 2005, established a common framework and scoring key that has undergone subsequent modification over the years, culminating in the publication of the ISTH-BAT in 2010. Understanding the normal range of bleeding scores is critical when assessing the utility of a BAT. Within the context of The Merging Project, a bioinformatics system was created to facilitate the merging of legacy data derived from four different (but all Vicenza-based) BATs; the MCMDM1-VWD BQ, the Condensed MCMDM-1VWD BQ, the Pediatric Bleeding Questionnaire and the ISTH-BAT. Data from 1040 normal adults and 328 children were included in the final analysis, which showed that the normal range is 0-3 for adult males, 0-5 for adult females and 0-2 in children for both males and females. Therefore, the cut-off for a positive or abnormal BS is ≥4 in adult males, ≥6 in adult females and ≥3 in children. This information can now be used to objectively assess bleeding symptoms as normal or abnormal in future studies.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  ISTH-BAT; bleeding questionnaire; bleeding score; normal range

Mesh:

Year:  2014        PMID: 25196510      PMCID: PMC4251588          DOI: 10.1111/hae.12503

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

1.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Creating an ontology-based human phenotyping system: The Rockefeller University bleeding history experience.

Authors:  Andreas C Mauer; Edward M Barbour; Nickolay A Khazanov; Natasha Levenkova; Shamim A Mollah; Barry S Coller
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

3.  The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

Authors:  F Rodeghiero; G Castaman; A Tosetto; J Batlle; F Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; A B Federici; S Lethagen; S Linari; A Srivastava
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

4.  Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire.

Authors:  M Bowman; J Riddel; M L Rand; A Tosetto; M Silva; P D James
Journal:  J Thromb Haemost       Date:  2009-05-30       Impact factor: 5.824

5.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

6.  Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

Authors:  A C Mauer; N A Khazanov; N Levenkova; S Tian; E M Barbour; C Khalida; J N Tobin; B S Coller
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

7.  Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease.

Authors:  M Bowman; G Mundell; J Grabell; W M Hopman; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824

  7 in total
  57 in total

1.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

Review 2.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

4.  Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.

Authors:  M Deforest; J Grabell; S Albert; J Young; A Tuttle; W M Hopman; P D James
Journal:  Haemophilia       Date:  2015-07-14       Impact factor: 4.287

Review 5.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

6.  Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study.

Authors:  Joline L Saes; Marieke J A Verhagen; Karina Meijer; Marjon H Cnossen; Roger E G Schutgens; Marjolein Peters; Laurens Nieuwenhuizen; Felix J M van der Meer; Ilmar C Kruis; Waander L van Heerde; Saskia E M Schols
Journal:  Blood Adv       Date:  2020-10-27

7.  The bleeding score: Useful in predicting spontaneous bleeding events in adults with bleeding of unknown cause?

Authors:  Nicole Relke; Shikha Kuthiala; Julie Grabell; Wilma M Hopman; Paula James
Journal:  Haemophilia       Date:  2019-05-20       Impact factor: 4.287

8.  New advances in the diagnosis of von Willebrand disease.

Authors:  Ruchika Sharma; Sandra L Haberichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 9.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 10.  Current controversies in the diagnosis and management of von Willebrand disease.

Authors:  Anne T Neff
Journal:  Ther Adv Hematol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.